HARP
|Harpoon Therapeutics Inc
NASDAQ
USD
|%
Current Price
Change
(%)
P/E Ratio
Dividend Yield
Market Cap
492.35M
Volume
Open
Previous Close
52-Week High
52-Week Low
About Harpoon Therapeutics Inc
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-...
Sector:Healthcare
Industry:Biotechnology
CEO:Ms. Julie M. Eastland M.B.A.
Employees:53
Headquarters:South San Francisco, USA
Website:www.harpoontx.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions